Iovance Biotherapeutics

About Iovance Biotherapeutics

Iovance Biotherapeutics is a biotechnology company focused on developing novel cancer immunotherapies using tumor-infiltrating lymphocyte (TIL) technology. Their primary customers are cancer patients and healthcare providers, particularly oncologists treating advanced solid tumors. The company's main product is lifileucel (Amtagvi), the first FDA-approved TIL therapy for metastatic melanoma, with other TIL therapies in development for various cancers. While primarily operating from research and manufacturing facilities, Iovance offers some remote and hybrid work options, particularly for corporate and administrative roles, though laboratory and manufacturing positions require on-site presence.

Company Culture

Iovance Biotherapeutics fosters a collaborative and mission-driven culture focused on advancing cancer treatments. Employees work in cross-functional teams combining scientific research, clinical development, and manufacturing expertise. The environment emphasizes innovation, scientific rigor, and patient-centric values, with a sense of urgency to bring transformative therapies to market.

Our Values

Patient-centric innovation, scientific excellence, collaborative teamwork, integrity in research and development, urgency in advancing cancer treatments, and commitment to improving patient outcomes.

Benefits & Perks

Iovance typically offers comprehensive health benefits including medical, dental, and vision coverage, along with retirement plans and equity incentives. The company provides professional development opportunities and may offer flexible work arrangements for eligible roles. Additional benefits often include paid time off, parental leave, and wellness programs common in the biotechnology industry.

Roles & Teams We Hire For

Skills & Tools You'll Use

Open Positions (1)